- Report
- September 2021
- 40 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
United States
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Saudi Arabia
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
India
From €1421EUR$1,500USD£1,200GBP
- Report
- September 2021
- 40 Pages
Vietnam
From €1421EUR$1,500USD£1,200GBP
- Report
- March 2024
- 234 Pages
Global
€4733EUR$4,995USD£3,994GBP
- Report
- August 2023
- 180 Pages
Global
From €3553EUR$3,750USD£2,999GBP
- Report
- September 2022
Global
€4990EUR$5,641USD£4,359GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €9429EUR$9,950USD£7,957GBP
- Report
- November 2020
- 450 Pages
Global
From €4643EUR$4,900USD£3,918GBP
- Report
- April 2019
- 180 Pages
China, Global
From €2843EUR$3,000USD£2,399GBP
- Report
- August 2024
- 69 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- January 2025
- 87 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- November 2024
- 100 Pages
Global
From €3500EUR$3,957USD£3,057GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more